{
    "2021-08-02": [
        [
            {
                "time": "2018-01-01",
                "original_text": "药明康德：根据2018年A股激励计划共约14.46万份股票期权可行权",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股票期权",
                        "激励计划"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-02",
                "original_text": "药明康德：拟将注册资本变更至29.53亿元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "注册资本",
                        "变更"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-01",
                "original_text": "国泰君安医药行业2021年8月投资策略：聚焦成长性 寻找向上变化的个股",
                "features": {
                    "keywords": [
                        "国泰君安",
                        "医药行业",
                        "投资策略",
                        "成长性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "兴业证券：7月金股组合亏损2.87% 8月荐股名单出炉",
                "features": {
                    "keywords": [
                        "兴业证券",
                        "金股组合",
                        "亏损"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "北向资金7月动向：重点进攻高景气成长制造主线，周期性行业遭抛售",
                "features": {
                    "keywords": [
                        "北向资金",
                        "高景气成长",
                        "周期性行业"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制造",
                        "周期性行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-01",
                "original_text": "医药行业周报：政策担忧不改医药高景气 疫情爆发带来疫苗阶段性机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "政策担忧",
                        "高景气",
                        "疫苗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-01",
                "original_text": "工银瑞信基金赵蓓：大举加仓医药龙头 独具风格挖掘成长股",
                "features": {
                    "keywords": [
                        "工银瑞信基金",
                        "赵蓓",
                        "医药龙头",
                        "成长股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-01",
                "original_text": "速递 | 治疗睡眠障碍，武田创新疗法获FDA突破性疗法认定",
                "features": {
                    "keywords": [
                        "武田",
                        "创新疗法",
                        "FDA",
                        "突破性疗法"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-01",
                "original_text": "速递 | 一剂降低新冠风险81%，中和抗体疗法获FDA紧急使用授权",
                "features": {
                    "keywords": [
                        "新冠",
                        "中和抗体疗法",
                        "FDA",
                        "紧急使用授权"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-01",
                "original_text": "前沿 | 像调节灯光一样调节基因疗法的表达水平，《自然》报道创新基因疗法设计",
                "features": {
                    "keywords": [
                        "基因疗法",
                        "《自然》",
                        "创新设计"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}